Related Blog Posts from the Wikinvest Wire

Thermo Fisher Scientific (TMO)   Subscribe to Thermo Fisher Scientific (TMO) content from the Wikinvest Wire
 » Back to Thermo Fisher S… (NYSE:TMO) Stock Page


12/10/13Company Update: Merck & Co. Inc. (NYSE:MRK) – Ex-Dividend Reminder: Merck, Owens & Minor and Th... (Jutia Group)

[at Forbes] - Looking at the universe of stocks we cover at Dividend Channel, on 12/12/13, Merck & Co., Inc (NYSE: MRK), Owens & Minor, Inc. (NYSE: OMI), and Thermo Fisher Scientific Inc (NYSE: TMO) will all trade ex-dividend for their respective upcoming dividends. Merck & Co., Inc will pay its quarterly dividend [...] [...]

4/27/13(LIFE) Thermo Fisher Scientific Wins Life Technologies Corporation Takeover Battle (Stock Blog Hub)

Finally, the much hyped takeover battle for Life Technologies Corporation (LIFE) came to an end on Monday with Thermo Fisher Scientific (TMO) emerging as the clear winner. The latter disclosed that it will acquire Life Technologies for roughly $13.6 billion (or $76 per share), plus the assumption of Life Technologies’ net debt ($2.2 billion as [...]

2/20/12Thermo Fisher Scientific Inc (NYSE:TMO) Stock Picks Among Top 50 Companies in Its Industry by EPS... (Penny Stock DD)

Daily Stock News: Thermo Fisher Scientific Inc (NYSE:TMO) stock picks moved down by 0.42 percent and closed at $56.38 whereas traded volume stood at 1.88 million shares for the last Friday Feb 17th trading session as compare to its average volume stood at 3.08 million. The RSI value of 72.16 times depicts that the current share value [...]

12/7/11Daily Market Update On Thermo Fisher Scientific Inc. (NYSE:TMO) Stock Picks (Penny Stock DD)

Stock Performance: Thermo Fisher Scientific Inc. (NYSE:TMO) moved down by 0.42% and closed at $46.98 whereas total traded volume stood at 2.92 million shares for the last trading session as compare to its average volume stood at 3.92 million. Its price to earnings ratio stands at 17.93 times. The company stands in profit with the profit [...]

11/30/11(TMO) Thermo Fisher Scientific Shares Maintained at Neutral (Stock Blog Hub)

Recently, we reiterated our Neutral recommendation on Thermo Fisher Scientific (TMO) with a target price of $47.00. Thermo Fisher continues to be focused on effectively deploying its cash balance to create value through share buybacks and suitable acquisitions. Significant acquisitions include that of Dionex Corporation and Phadia. The former brings in ion and liquid chromatography portfolio [...]

10/24/11Thermo Fisher Scientific Earnings Estimate $TMO (Robert Weinstein Trading Blog)

Earnings Overview for Thermo Fisher Scientific Inc. (TMO) By Robert Weinstein Thermo Fisher Scientific Inc. (TMO) is expected to report earnings for last fiscal quarter before the opening bell on October 26, 2011. TMO trades an average of 3.8 million shares per day. Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services [...]

7/27/11UPDATE: Thermo Fisher Reports Strong Rise In Q2 Profit, Raises 2011 Earnings Forecast (Phil’s Stock World)

Courtesy of Benzinga Thermo Fisher Scientific Inc (NYSE: TMO) reported a rise in its second-quarter net profit and lifted its earnings forecast for the year. [...]

5/26/11Microcap Biotechs Offer Superior Reward/Risk (Wall Street Sector Selector)

Genomic stocks seem to be overcoming concern over government budget and grant cuts. The 800-pound gorillas like Agilent (A) and Illumina (ILMN) continue to put forth impression quarterly numbers, which lends support to the entire sector. Our trio has a...

5/22/11NYSE Stocks at Overbought Level: (BKS, TMO) (Penny Stock DD)

Barnes & Noble, Inc. (NYSE:BKS) went up by 29.91% to close at $18.33 with overall traded volume of 11.38 million shares in the last trading day. Its outstanding share stood at 60.25 million shares. Its total market capitalization arrived at $1.10 billion. Thermo Fisher Scientific Inc. (NYSE:TMO) plunged by 0.31% and closed at $65.18 whereas [...]

12/13/10Thermo Fisher Scientific Pops on Dionex Acquisition (Penny Stock DD)

Thermo Fisher Scientific (TMO - option chain) shares are rising today after the company announced this morning that it will acquire all outstanding shares of Dionex Corp. (DNEX) for $188.50 per share in cash, for a total cost of $2.1 billion. TMO expects the deal to close in the first quarter of 2011. [...]

10/28/10Goldman Sachs Revises Thermo Fisher Scientific Estimates And Price Target (Benzinga)

Thermo Fisher Scientific, Inc. (NYSE: TMO) reported 3Q2010 revenues/EPS of $2.68b/$0.90 that “beat our $2.61b/$0.81 estimates and consensus of $2.59b/$0.83,” Goldman Sachs reports. Organic revenue growth of 4% exceeded expectations by 100bps and combined with solid margins to yield a clean beat for the quarter. “We are revising our 2010-2012 estimates to $3.52/$3.96/$4.28 from $3.45/$3.86/$4.23 to reflect the strength in the Analytical Technologies division, higher FY2010 guidance,...

10/18/10Thermo Fisher Scientific Forms Advisory Board (Benzinga)

Thermo Fisher Scientific Inc. (NYSE: TMO) today announced that it has formed a Scientific Advisory Board to formalize the two-way exchange of technological information between the company and representatives from some of the world's premiere centers of health, science and education. “Scientific discovery is often the catalyst for change,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “The insight and distinct expertise of each member of our...

4/19/10(TMO) Thermo Fisher Scientific Announces Aquisition of Proxeon (Stock Blog Hub)

Thermo Fisher Scientific Inc. (TMO) announced that it has acquired Proxeon A/S, an innovative supplier of products for proteomics analysis. Financial terms of the transaction have not been disclosed. Thermo Fisher plans to integrate Proxeon into its Analytical Technologies Segment. The company does not expect the acquisition to have a material impact on its fiscal 2010 [...]

4/14/10(TMO) Thermo Fisher Scientific Analyst Remains Neutral (Stock Blog Hub)

We have retained our ‘Neutral’ rating on Thermo Fisher Scientific, Inc. (TMO) with a target price of $55 based on a P/E of 16.2 and our fiscal 2010 EPS estimate of $3.39. The company’s results for the fourth quarter and fiscal 2009 were mixed. Thermo Fisher Scientific reported fourth-quarter earnings per share of 91 cents, surpassing [...]

3/29/10(TMO) Thermo Fisher Scientific Expands Agreement with Eli Lilly (Stock Blog Hub)

Thermo Fisher Scientific Inc. (TMO) recently expanded its clinical trial materials supply chain relationship agreement with Eli Lilly and Company (LLY). Per the new five-year agreement, Thermo Fisher will take over the responsibility of Lilly’s in-house clinical trial materials manufacturing, packaging and labeling operations at the Lilly Technology Center in Indianapolis. The Fisher Clinical Services segment [...]

3/9/10(TMO) Thermo Fisher Scientific Acquires Finnzymes (Stock Blog Hub)

Thermo Fisher Scientific, Inc. (TMO) recently completed the acquisition of Finnzymes. Financial terms of the agreement have not been disclosed. The acquisition is not expected to have any material impact on the company’s financial results in fiscal 2010. Finnzymes is a Finland-based provider of integrated tools for molecular biology analysis, including reagents, instruments, consumables and kits. [...]

3/1/10(TMO) Thermo Fisher Scientific Acquires Ahura (Stock Blog Hub)

Thermo Fisher Scientific, Inc. (TMO) recently completed the acquisition of Ahura Scientific for $145 million in cash plus the potential for an earn-out payment based on the achievement of certain 2010 financial targets. Thermo Fisher has now decided to integrate Ahura into its Analytical Technologies Segment. Ahura Scientific is a leader in handheld Raman and FT-IR [...]

2/4/10(TMO) Thermo Fisher Scientific Surpasses Analyst Estimates (Stock Blog Hub)

Thermo Fisher Scientific, Inc. (TMO) reported fourth quarter and full fiscal 2009 results. For the fourth quarter, earnings per share were 91 cents, surpassing the Zacks Consensus Estimate of 88 cents and the year-ago earnings of 87 cents. For fiscal 2009, earnings per share were $3.05, compared to the Zacks Consensus Estimate of $3.02 and [...]

2/4/10(TMO) Thermo Fisher Scientific to Acquire Finnzymes (Stock Blog Hub)

Thermo Fisher Scientific Inc. (TMO) has recently signed an agreement to acquire Finnzymes, a provider of integrated tools for molecular biology analysis, including reagents, instruments, consumables and kits. Financial terms of the agreement have not been disclosed. Thermo Fisher expects to complete the acquisition in the first quarter of fiscal 2010. The acquisition is not [...]

1/8/10(TMO) Thermo Fisher Scientific Analysts Initiate Coverage at Neutral (Stock Blog Hub)

We recently initiated coverage on Thermo Fisher Scientific, Inc. (TMO) with a Neutral recommendation. We rate the stock as Neutral with a target price of $50 based on a P/E of 15.0x our fiscal 2010 EPS estimate of $3.33. Thermo Fisher reported third quarter fiscal 2009 earnings per share of 78 cents, surpassing both the Zacks [...]

12/17/09(TMO) Thermo Fisher Scientific Earns New National Institutes of Health Contract (Stock Blog Hub)

Thermo Fisher Scientific Inc. (TMO) recently received a new contract from the consortium of U.S. National Institutes of Health, Centers for Disease Control and Prevention and the Environmental Protection Agency. Thermo Fisher has been selected as the National Children’s Study (NCS) biological and environmental sample repository partner in the contract. Financial terms of the contract [...]

11/16/09(TMO) Thermo Fisher Scientific to Sell $350 Million in Notes (Stock Blog Hub)

Thermo Fisher Scientific Inc. (TMO) decided to sell senior notes for refinancing certain of its outstanding indebtedness. The notes offered are $350 million aggregate principal amount of 2.15% senior notes due 2012 and $400 million aggregate principal amount of 3.25% senior notes due 2014. Issue prices are 99.855% of the principal amount of the 2012 [...]

10/26/09(TMO) Thermo Fisher Scientific Meets Expectations (Stock Blog Hub)

Thermo Fisher Scientific Inc. (TMO) today reported financial results for the third quarter of fiscal 2009. Earnings per share came in at 78 cents, exceeding both the Zacks Consensus Estimate and the year-ago earnings of 75 cents. Net sales declined 2% year over year to $2.5 billion. The decline was due to lower Analytical Technologies revenues, [...]

10/13/09(TMO) Thermo Fisher Scientific Issues Public Notice on Debenture Conversion (Stock Blog Hub)

Thermo Fisher Scientific Inc. (TMO) recently began the process of issuing public notice to the holders of Floating Rate Convertible Senior Debentures of Apogent Technologies Inc. that are due in 2033, reminding them of their rights to convert the debentures. Thermo Fisher accepted this debt as part of its acquisition of Fisher Scientific International Inc. [...]

9/10/09(TMO) Thermo Fisher Scientific Inc Buys BRAHMS (Stock Blog Hub)

Thermo Fisher Scientific Inc. (TMO) recently agreed to acquire B.R.A.H.M.S. AG for 330 million Euros or about $470 million. B.R.A.H.M.S. is a leading provider of specialty in-vitro diagnostic tests based on its patented biomarkers for sepsis, cardiovascular and pulmonary diseases, as well as intensive care treatments and prenatal screening. The company is based outside of [...]

1/18/07Netflix Exec Provides TMO With Clarifications on Mac Support (Venture Chronicles)

Netflix's new streaming service is really exciting, unless you are a Mac user in which case the Microsoft DRM they are using makes it incompatible. Bummer. On a related note, the "view once" delivery model makes me uncomfortable, I would much more prefer a "view 3 times" or some variation. A lot can happen with [...]

8/16/06Wikis That Work Series (Venture Chronicles)

I needed a little help getting my new phone configured for T-Mobile's service in my area... forget figuring anything out on the TMO website... so I went to the always trusty forums on HowardForums. Rarely has there been a question that I have not found an answer to by searching or posting to this forum. [...]

Your blog posts can appear here by joining the Wikinvest Wire
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki